Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Evaluation of an Imaging Protocol to Identify Lymph Nodes and Organs of Interest in Patients with Urologic Cancer During Surgery

Trial Status: active

This clinical trial evaluates the effectiveness of an imaging protocol using electromagnetic (EM) sensors combined with laparoscopic and ultrasound imaging during surgical procedures in patients with urologic cancers. Part of standard of care for a tumor within a urologic region such as the bladder, prostate, testicle, kidney, urethra, and penis, is to remove the affected lymph node and/or urologic organ. During the surgical procedure, it is not always obvious which lymph nodes or urologic organs are involved. The sensors, attached to a laparoscope and ultrasound probe, use EM technology to create detailed, three dimensional, digital images of a target location to help the surgeon find the location of urologic regions of interest. A laparoscope is a long thin tube with a camera attached that allows the doctor to see the organs inside the abdomen and may also have a tool to remove tissue. Ultrasound uses high-frequency waves to produce images of the body. Using an image guidance protocol, such as EM sensors combined with laparoscope and ultrasound imaging, may allow surgeons to better find the location of lymph node(s) and the organs of interest during surgery and may improve outcomes in patients with urologic cancers.